ACE and coronary artery disorder: With a relatively poor prognosis [27] and an increased likelihood of subsequent all-cause and CHD-related mortality being found for this cohort, heart failure was found in proportionally more patients receiving ACE-inhibitors than those that didn't receive the therapy.